All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Combination therapy in patients with Philadelphia chromosome-negative B-ALL
Acute lymphoblastic leukemia (ALL) is a type of hematologic cancer of immature lymphocytes in the bone marrow, which most commonly affects children but also occurs in...
Which tests are needed for risk stratification in ALL
During the last steering committee (SC) meeting, held on May 19, 2022, the SC members discussed the tests needed for risk stratification in ALL. The session was chaired by Jan Cools and included...
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.